Yacobi Brothers Group (YSB) Ltd (TLV:YACO)

Verve Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	131	69	88	77	128	73
Market Cap Growth	-20.66%	-21.63%	14.75%	-39.94%	74.56%	28.38%
Enterprise Value	297	237	243	209	266	181
Last Close Price	0.73	0.38	0.49	0.43	0.71	0.48
PE Ratio	-	-	-	3.54	-	1.32
PS Ratio	0.42	0.22	0.26	0.25	0.34	0.18
PB Ratio	0.65	0.35	0.41	0.35	0.65	0.38
P/TBV Ratio	0.68	0.36	0.42	0.36	0.67	0.40
P/FCF Ratio	66.84	35.30	-	-	-	-
P/OCF Ratio	21.78	11.50	21.99	-	-	-
EV/Sales Ratio	0.95	0.76	0.70	0.68	0.70	0.43
EV/EBITDA Ratio	12.38	107.31	32.67	54.22	53.96	-
EV/EBIT Ratio	23.81	-	64.36	-	-	-
EV/FCF Ratio	151.43	120.95	-	-	-	-
Debt / Equity Ratio	0.86	0.86	0.72	0.66	0.71	0.64
Debt / EBITDA Ratio	16.35	16.35	12.04	38.15	28.47	-
Debt / FCF Ratio	87.58	87.58	-	-	-	-
Asset Turnover	0.62	0.62	0.69	0.61	0.75	0.75
Inventory Turnover	17.74	17.74	20.68	20.82	32.41	40.51
Quick Ratio	0.72	0.72	1.10	1.28	1.40	0.97
Current Ratio	0.83	0.83	1.24	1.46	1.54	1.09
Return on Equity (ROE)	-7.45%	-7.45%	-2.09%	10.37%	-4.64%	-21.64%
Return on Assets (ROA)	-0.12%	-0.12%	0.47%	-0.68%	-0.55%	-2.53%
Return on Capital (ROIC)	-0.17%	-0.17%	0.64%	-0.97%	-0.84%	-4.56%
Return on Capital Employed (ROCE)	-	-	1.10%	-	-	-
Earnings Yield	-11.86%	-22.45%	-5.18%	28.28%	-4.86%	75.59%
FCF Yield	1.50%	2.83%	-4.57%	-43.42%	-42.73%	-114.40%
Buyback Yield / Dilution	-	-	-	-14.55%	-13.39%	-4.10%

Updated Aug 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.